Oct-1 is involved in the transcriptional repression of the von Willebrand factor gene promoter

Blood

Volumn 92, Issue 4, 1998, Pages 1247-1258

  Schwachtgen, Jean Luc ^a   Remacle, Jacques E ^b   Janel, Nathalie ^b   Brys, Reginald ^b   Huylebroeck, Danny ^b   Meyer, Dominique ^b   Kerbiriou Nabias, Danièle ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VON WILLEBRAND FACTOR;

ARTICLE; BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; VON WILLEBRAND DISEASE;

EID: 0032529521     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1247.416k08_1247_1258     Document Type: Article

References (56)

1. Mazurier C, Meyer D: Molecular basis of von Willebrand disease. Clin Haematol 9:229, 1996
2. Sadler JE, Matsushita T, Dong Z, Tuley EA, Westfield LA: Molecular mechanism and classification of von Willebrand disease. Thromb Haemost 74:161, 1995
3. Nachman R, Levine R, Jaffe EA: Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 60:914, 1977
4. Jaffe EA, Hoyer LW, Nachman RL: Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71:1906, 1974
5. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745, 1973
6. Coffin JD, Harrison J, Schwartz S, Heimark R: Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol 148:51, 1991
7. Smith JM, Meinkoth JH, Hochstatter T, Meyers KM: Differential distribution of von Willebrand factor in canine vascular endothelium. Am J Vet Res 57:750, 1996
8. Bahnak BR, Wu QY, Coulombel L, Assouline Z, Kerbiriou-Nabias D, Piétu G, Drouet L, Caen JP, Meyer D: Expression of von Willebrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol 138:305, 1989
9. Collins CJ, Underdahl JP, Levene RB, Ravera CP, Morin MJ, Dombalagian MJ, Ricca G, Livingston DM, Lynch DC: Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site. Proc Natl Acad Sci USA 84:4393, 1987
10. Assouline Z, Kerbiriou-Nabias DM, Pietu G, Thomas N, Bahnak BR, Meyer D: The human gene for von Willebrand factor. Identification of repetitive Alu sequences 5′ to the transcription initiation site. Biochem Biophys Res Commun 153:1159, 1988
11. Bonthron D, Orkin SH: The human von Willebrand factor gene. Structure of the 5′ region. Eur J Biochem 171:51, 1988
12. Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE: Structure of the gene for human von Willebrand factor. J Biol Chem 264:19514, 1989
13. Ferreira V, Assouline Z, Schwachtgen JL, Bahnak BR, Meyer D, Kerbiriou-Nabias D: The role of the 5′-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem J 293:641, 1993
14. Jahroudi N, Lynch DC: Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 14:999, 1994
15. Jahroudi N, Ardekani AM, Greenberger JS: An NF1-like protein functions as a repressor of the von Willebrand factor promoter. J Biol Chem 271:21413, 1996
16. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD: Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA 92:4567, 1995
17. Iademarco MF, McQuillan JJ, Dean DC: Vascular cell adhesion molecule 1: Contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci USA 90:3943, 1993
18. Frebourg T, Brison O: Plasmid vectors with multiple cloning sites and cat-reporter gene for promoter cloning and analysis in animal cells. Gene 65:315, 1988
19. Luckow B, Schutz G: CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 15:5490, 1987
20. Hoshi H, McKeehan WL: Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture. Proc Natl Acad Sci USA 81:6413, 1984
21. Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, Struhl K: Current Protocols in Molecular Biology. New York, NY, Wiley, 1987
22. Schwachtgen JL, Ferreira V, Meyer D, Kerbiriou-Nabias D: Optimization of the transfection of human endothelial cells by electroporation. Biotechniques 17:882, 1994
23. Rouet P, Raguenez G, Salier JP: Optimized assays for quantifying transient expressions of co-transfected beta-galactosidase and CAT reporter genes. Biotechniques 13:700, 1992
24. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475, 1983
25. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
26. Giguere V, McBroom LD, Flock G: Determinants of target gene specificity for ROR alpha 1 : Monomeric DNA binding by an orphan nuclear receptor. Mol Cell Biol 15:2517, 1995
27. Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G: Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 8:538, 1994
28. Chodosh LA, Baldwin AS, Carthew RW, Sharp PA: Human CCAAT-binding proteins have heterologous subunits. Cell 53:11, 1987
29. Lee ME, Temizer DH, Clifford JA, Quertermous T: Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 266:16188, 1991
30. Dorfman DM, Wilson DB, Bruns GA, Orkin SH: Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 267:1279, 1992
31. Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ: Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: Identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 89:1260, 1997
32. Zhang R, Min W, Sessa WC: Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 270:15320, 1995
33. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH: GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol 13:668, 1993
34. Hashimoto Y, Ware J: Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. J Biol Chem 270:24532, 1995
35. Hickey MJ, Roth GJ: Characterization of the gene encoding human platelet glycoprotein IX. J Biol Chem 268:3438, 1993
36. Uzan G, Prandini MH, Berthier R: Regulation of gene transcription during the differentiation of megakaryocytes. Thromb Haemost 74:210, 1995
37. Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V: Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 87:4678, 1996
38. Prandini MH, Martin F, Thevenon D, Uzan G: The tissue-specific transcriptional regulation of the megakaryocytic glycoprotein IIb gene is controlled by interactions between a repressor and positive cis-acting elements. Blood 88:2062, 1996
39. Schwachtgen JL, Janel N, Barek L, Duterque-Coquillaud M, Ghysdael J, Meyer D, Kerbiriou-Nabias D: Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Oncogene 15:3091, 1997
40. Ades SE, Sauer RT: Specificity of minor-groove and major-groove interactions in a homeodomain-DNA complex. Biochemistry 34:14601, 1995
41. Kissinger CR, Liu BS, Martin-Blanco E, Kornberg TB, Pabo CO: Crystal structure of an engrailed homeodomain-DNA complex at 2.8 A resolution: A framework for understanding homeodomain-DNA interactions. Cell 63:579, 1990
42. Wintjens R, Rooman M: Structural classification of HTH DNA-binding domains and protein-DNA interaction modes. J Mol Biol 262:294, 1996
43. Wolberger C: Homeodomain interactions. Curr Opin Struct Biol 6:62, 1996
44. Clerc RG, Corcoran LM, LeBowitz JH, Baltimore D, Sharp PA: The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. Genes Dev 2:1570, 1988
45. Verrijzer CP, Alkema MJ, van Weperen WW, van Leeuwen HC, Strating MJ, van der Vliet PC: The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J 11:4993, 1992
46. Klemm JD, Rould MA, Aurora R, Herr W, Pabo CO: Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21, 1994
47. Cox M, van Tilborg PJ, de Laat W, Boelens R, van Leeuwen HC, van der Vliet PC, Kaptein R: Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics. J Biomol NMR 6:23, 1995
48. Bendall AJ, Sturm RA, Danoy PA, Molloy PL: Broad binding-site specificity and affinity properties of octamer 1 and brain octamer-binding proteins. Eur J Biochem 217:799, 1993
49. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323, 1992
50. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T: Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176:1583, 1992
51. Sheppard AM, McQuillan JJ, Iademarco MF, Dean DC: Control of vascular cell adhesion molecule-1 gene promoter activity during neural differentiation. J Biol Chem 270:3710, 1995
52. Delhase M, Castrillo JL, de la Hoya M, Rajas F, Hooghe-Peters EL: AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. J Biol Chem 271:32349, 1996
53. Liu YZ, Latchman DS: The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat. Biochem J 322:155, 1997
54. Kim MK, Lesoon-Wood LA, Weintraub BD, Chung JH: A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain. Mol Cell Biol 16:4366, 1996
55. Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD: Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 138:1117, 1997
56. Scholer HR: Octamania: The POU factors in murine development. Trends Genet 7:323, 1991